HEADER ANTITUMOR PROTEIN 24-OCT-22 8H8X TITLE CRYO-EM STRUCTURE OF HACE1 MONOMER COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE HACE1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HECT DOMAIN AND ANKYRIN REPEAT-CONTAINING E3 UBIQUITIN- COMPND 5 PROTEIN LIGASE 1,HECT-TYPE E3 UBIQUITIN TRANSFERASE HACE1; COMPND 6 EC: 2.3.2.26; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HACE1, KIAA1320; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS E3 UBIQUITIN LIGASE, TUMOR SUPPRESSOR, POST-TRANSLATIONAL MODIFIER, KEYWDS 2 PROTEIN DEGRADATION, ANTITUMOR PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.SINGH,S.MACHIDA,N.K.TULSIAN,Y.K.CHOONG,J.NG,S.SHANKER,L.D.YAOCHEN, AUTHOR 2 J.SHI,J.SIVARAMAN REVDAT 2 10-JAN-24 8H8X 1 JRNL REVDAT 1 28-JUN-23 8H8X 0 JRNL AUTH S.SINGH,S.MACHIDA,N.K.TULSIAN,Y.K.CHOONG,J.NG,S.SHANKAR, JRNL AUTH 2 Y.LIU,K.V.CHANDIRAMANI,J.SHI,J.SIVARAMAN JRNL TITL STRUCTURAL BASIS FOR THE ENZYMATIC ACTIVITY OF THE HACE1 JRNL TITL 2 HECT-TYPE E3 LIGASE THROUGH N-TERMINAL HELIX DIMERIZATION. JRNL REF ADV SCI V. 10 07672 2023 JRNL REFN ESSN 2198-3844 JRNL PMID 37537642 JRNL DOI 10.1002/ADVS.202207672 REMARK 2 REMARK 2 RESOLUTION. 3.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.920 REMARK 3 NUMBER OF PARTICLES : 269682 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8H8X COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1300033066. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HACE1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 386 REMARK 465 GLU A 387 REMARK 465 ILE A 388 REMARK 465 THR A 389 REMARK 465 SER A 390 REMARK 465 ILE A 391 REMARK 465 LEU A 392 REMARK 465 LEU A 393 REMARK 465 LYS A 394 REMARK 465 GLN A 395 REMARK 465 LYS A 396 REMARK 465 GLY A 397 REMARK 465 GLN A 398 REMARK 465 ASP A 399 REMARK 465 GLN A 400 REMARK 465 ASP A 401 REMARK 465 ALA A 402 REMARK 465 ALA A 403 REMARK 465 SER A 404 REMARK 465 ILE A 405 REMARK 465 PRO A 406 REMARK 465 PRO A 407 REMARK 465 PHE A 408 REMARK 465 GLU A 409 REMARK 465 PRO A 410 REMARK 465 PRO A 411 REMARK 465 GLY A 412 REMARK 465 PRO A 413 REMARK 465 GLY A 414 REMARK 465 SER A 415 REMARK 465 TYR A 416 REMARK 465 GLU A 417 REMARK 465 ASN A 418 REMARK 465 LEU A 419 REMARK 465 SER A 420 REMARK 465 THR A 421 REMARK 465 GLY A 422 REMARK 465 THR A 423 REMARK 465 ARG A 424 REMARK 465 GLU A 425 REMARK 465 SER A 426 REMARK 465 LYS A 427 REMARK 465 PRO A 428 REMARK 465 ASP A 429 REMARK 465 ALA A 430 REMARK 465 LEU A 431 REMARK 465 ALA A 432 REMARK 465 GLY A 433 REMARK 465 ARG A 434 REMARK 465 GLN A 435 REMARK 465 GLU A 436 REMARK 465 ALA A 437 REMARK 465 SER A 438 REMARK 465 ALA A 439 REMARK 465 ASP A 440 REMARK 465 CYS A 441 REMARK 465 THR A 907 REMARK 465 MET A 908 REMARK 465 ALA A 909 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN A 209 OG1 THR A 212 2.10 REMARK 500 O LYS A 305 OG SER A 308 2.11 REMARK 500 NH1 ARG A 143 OE2 GLU A 145 2.17 REMARK 500 O GLN A 734 NZ LYS A 737 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 156 33.83 -93.74 REMARK 500 ARG A 210 -63.89 -97.68 REMARK 500 LYS A 350 -10.90 75.77 REMARK 500 THR A 351 73.76 53.36 REMARK 500 GLN A 466 31.02 -91.15 REMARK 500 PHE A 515 37.82 -98.49 REMARK 500 HIS A 534 53.12 -92.31 REMARK 500 LEU A 535 -40.15 -130.50 REMARK 500 PRO A 540 79.27 -69.77 REMARK 500 ASP A 541 52.33 -97.31 REMARK 500 SER A 542 -7.20 73.44 REMARK 500 MET A 544 54.39 -90.91 REMARK 500 VAL A 545 -63.57 -131.20 REMARK 500 LYS A 579 32.37 -92.40 REMARK 500 ASN A 610 103.67 -58.27 REMARK 500 HIS A 637 -56.31 -122.73 REMARK 500 SER A 709 113.30 -165.85 REMARK 500 ASP A 777 -168.11 -75.74 REMARK 500 GLU A 809 30.50 -142.23 REMARK 500 THR A 824 -167.54 -77.69 REMARK 500 PRO A 886 9.18 -68.01 REMARK 500 ASP A 893 -62.55 -95.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 HIS A 534 LEU A 535 144.57 REMARK 500 LEU A 706 THR A 707 -148.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-34551 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF HACE1 MONOMER DBREF 8H8X A 1 909 UNP Q8IYU2 HACE1_HUMAN 1 909 SEQRES 1 A 909 MET GLU ARG ALA MET GLU GLN LEU ASN ARG LEU THR ARG SEQRES 2 A 909 SER LEU ARG ARG ALA ARG THR VAL GLU LEU PRO GLU ASP SEQRES 3 A 909 ASN GLU THR ALA VAL TYR THR LEU MET PRO MET VAL MET SEQRES 4 A 909 ALA ASP GLN HIS ARG SER VAL SER GLU LEU LEU SER ASN SEQRES 5 A 909 SER LYS PHE ASP VAL ASN TYR ALA PHE GLY ARG VAL LYS SEQRES 6 A 909 ARG SER LEU LEU HIS ILE ALA ALA ASN CYS GLY SER VAL SEQRES 7 A 909 GLU CYS LEU VAL LEU LEU LEU LYS LYS GLY ALA ASN PRO SEQRES 8 A 909 ASN TYR GLN ASP ILE SER GLY CYS THR PRO LEU HIS LEU SEQRES 9 A 909 ALA ALA ARG ASN GLY GLN LYS LYS CYS MET SER LYS LEU SEQRES 10 A 909 LEU GLU TYR SER ALA ASP VAL ASN ILE CYS ASN ASN GLU SEQRES 11 A 909 GLY LEU THR ALA ILE HIS TRP LEU ALA VAL ASN GLY ARG SEQRES 12 A 909 THR GLU LEU LEU HIS ASP LEU VAL GLN HIS VAL SER ASP SEQRES 13 A 909 VAL ASP VAL GLU ASP ALA MET GLY GLN THR ALA LEU HIS SEQRES 14 A 909 VAL ALA CYS GLN ASN GLY HIS LYS THR THR VAL GLN CYS SEQRES 15 A 909 LEU LEU ASP SER GLY ALA ASP ILE ASN ARG PRO ASN VAL SEQRES 16 A 909 SER GLY ALA THR PRO LEU TYR PHE ALA CYS SER HIS GLY SEQRES 17 A 909 GLN ARG ASP THR ALA GLN ILE LEU LEU LEU ARG GLY ALA SEQRES 18 A 909 LYS TYR LEU PRO ASP LYS ASN GLY VAL THR PRO LEU ASP SEQRES 19 A 909 LEU CYS VAL GLN GLY GLY TYR GLY GLU THR CYS GLU VAL SEQRES 20 A 909 LEU ILE GLN TYR HIS PRO ARG LEU PHE GLN THR ILE ILE SEQRES 21 A 909 GLN MET THR GLN ASN GLU ASP LEU ARG GLU ASN MET LEU SEQRES 22 A 909 ARG GLN VAL LEU GLU HIS LEU SER GLN GLN SER GLU SER SEQRES 23 A 909 GLN TYR LEU LYS ILE LEU THR SER LEU ALA GLU VAL ALA SEQRES 24 A 909 THR THR ASN GLY HIS LYS LEU LEU SER LEU SER SER ASN SEQRES 25 A 909 TYR ASP ALA GLN MET LYS SER LEU LEU ARG ILE VAL ARG SEQRES 26 A 909 MET PHE CYS HIS VAL PHE ARG ILE GLY PRO SER SER PRO SEQRES 27 A 909 SER ASN GLY ILE ASP MET GLY TYR ASN GLY ASN LYS THR SEQRES 28 A 909 PRO ARG SER GLN VAL PHE LYS PRO LEU GLU LEU LEU TRP SEQRES 29 A 909 HIS SER LEU ASP GLU TRP LEU VAL LEU ILE ALA THR GLU SEQRES 30 A 909 LEU MET LYS ASN LYS ARG ASP SER THR GLU ILE THR SER SEQRES 31 A 909 ILE LEU LEU LYS GLN LYS GLY GLN ASP GLN ASP ALA ALA SEQRES 32 A 909 SER ILE PRO PRO PHE GLU PRO PRO GLY PRO GLY SER TYR SEQRES 33 A 909 GLU ASN LEU SER THR GLY THR ARG GLU SER LYS PRO ASP SEQRES 34 A 909 ALA LEU ALA GLY ARG GLN GLU ALA SER ALA ASP CYS GLN SEQRES 35 A 909 ASP VAL ILE SER MET THR ALA ASN ARG LEU SER ALA VAL SEQRES 36 A 909 ILE GLN ALA PHE TYR MET CYS CYS SER CYS GLN MET PRO SEQRES 37 A 909 PRO GLY MET THR SER PRO ARG PHE ILE GLU PHE VAL CYS SEQRES 38 A 909 LYS HIS ASP GLU VAL LEU LYS CYS PHE VAL ASN ARG ASN SEQRES 39 A 909 PRO LYS ILE ILE PHE ASP HIS PHE HIS PHE LEU LEU GLU SEQRES 40 A 909 CYS PRO GLU LEU MET SER ARG PHE MET HIS ILE ILE LYS SEQRES 41 A 909 ALA GLN PRO PHE LYS ASP ARG CYS GLU TRP PHE TYR GLU SEQRES 42 A 909 HIS LEU HIS SER GLY GLN PRO ASP SER ASP MET VAL HIS SEQRES 43 A 909 ARG PRO VAL ASN GLU ASN ASP ILE LEU LEU VAL HIS ARG SEQRES 44 A 909 ASP SER ILE PHE ARG SER SER CYS GLU VAL VAL SER LYS SEQRES 45 A 909 ALA ASN CYS ALA LYS LEU LYS GLN GLY ILE ALA VAL ARG SEQRES 46 A 909 PHE HIS GLY GLU GLU GLY MET GLY GLN GLY VAL VAL ARG SEQRES 47 A 909 GLU TRP PHE ASP ILE LEU SER ASN GLU ILE VAL ASN PRO SEQRES 48 A 909 ASP TYR ALA LEU PHE THR GLN SER ALA ASP GLY THR THR SEQRES 49 A 909 PHE GLN PRO ASN SER ASN SER TYR VAL ASN PRO ASP HIS SEQRES 50 A 909 LEU ASN TYR PHE ARG PHE ALA GLY GLN ILE LEU GLY LEU SEQRES 51 A 909 ALA LEU ASN HIS ARG GLN LEU VAL ASN ILE TYR PHE THR SEQRES 52 A 909 ARG SER PHE TYR LYS HIS ILE LEU GLY ILE PRO VAL ASN SEQRES 53 A 909 TYR GLN ASP VAL ALA SER ILE ASP PRO GLU TYR ALA LYS SEQRES 54 A 909 ASN LEU GLN TRP ILE LEU ASP ASN ASP ILE SER ASP LEU SEQRES 55 A 909 GLY LEU GLU LEU THR PHE SER VAL GLU THR ASP VAL PHE SEQRES 56 A 909 GLY ALA MET GLU GLU VAL PRO LEU LYS PRO GLY GLY GLY SEQRES 57 A 909 SER ILE LEU VAL THR GLN ASN ASN LYS ALA GLU TYR VAL SEQRES 58 A 909 GLN LEU VAL THR GLU LEU ARG MET THR ARG ALA ILE GLN SEQRES 59 A 909 PRO GLN ILE ASN ALA PHE LEU GLN GLY PHE HIS MET PHE SEQRES 60 A 909 ILE PRO PRO SER LEU ILE GLN LEU PHE ASP GLU TYR GLU SEQRES 61 A 909 LEU GLU LEU LEU LEU SER GLY MET PRO GLU ILE ASP VAL SEQRES 62 A 909 SER ASP TRP ILE LYS ASN THR GLU TYR THR SER GLY TYR SEQRES 63 A 909 GLU ARG GLU ASP PRO VAL ILE GLN TRP PHE TRP GLU VAL SEQRES 64 A 909 VAL GLU ASP ILE THR GLN GLU GLU ARG VAL LEU LEU LEU SEQRES 65 A 909 GLN PHE VAL THR GLY SER SER ARG VAL PRO HIS GLY GLY SEQRES 66 A 909 PHE ALA ASN ILE MET GLY GLY SER GLY LEU GLN ASN PHE SEQRES 67 A 909 THR ILE ALA ALA VAL PRO TYR THR PRO ASN LEU LEU PRO SEQRES 68 A 909 THR SER SER THR CYS ILE ASN MET LEU LYS LEU PRO GLU SEQRES 69 A 909 TYR PRO SER LYS GLU ILE LEU LYS ASP ARG LEU LEU VAL SEQRES 70 A 909 ALA LEU HIS CYS GLY SER TYR GLY TYR THR MET ALA HELIX 1 AA1 ARG A 3 ARG A 17 1 15 HELIX 2 AA2 GLU A 28 ALA A 40 1 13 HELIX 3 AA3 GLN A 42 LEU A 50 1 9 HELIX 4 AA4 SER A 67 GLY A 76 1 10 HELIX 5 AA5 VAL A 78 LYS A 87 1 10 HELIX 6 AA6 THR A 100 GLY A 109 1 10 HELIX 7 AA7 GLN A 110 TYR A 120 1 11 HELIX 8 AA8 THR A 133 ASN A 141 1 9 HELIX 9 AA9 THR A 144 GLN A 152 1 9 HELIX 10 AB1 THR A 166 GLY A 175 1 10 HELIX 11 AB2 HIS A 176 SER A 186 1 11 HELIX 12 AB3 THR A 199 GLY A 208 1 10 HELIX 13 AB4 ARG A 210 ARG A 219 1 10 HELIX 14 AB5 PRO A 232 GLY A 240 1 9 HELIX 15 AB6 TYR A 241 HIS A 252 1 12 HELIX 16 AB7 ARG A 254 GLN A 261 1 8 HELIX 17 AB8 ARG A 269 SER A 284 1 16 HELIX 18 AB9 SER A 284 SER A 308 1 25 HELIX 19 AC1 ASN A 312 GLY A 334 1 23 HELIX 20 AC2 THR A 351 GLN A 355 5 5 HELIX 21 AC3 PHE A 357 PRO A 359 5 3 HELIX 22 AC4 LEU A 360 LYS A 382 1 23 HELIX 23 AC5 ASP A 443 SER A 464 1 22 HELIX 24 AC6 SER A 473 HIS A 483 1 11 HELIX 25 AC7 HIS A 483 ASN A 494 1 12 HELIX 26 AC8 PRO A 495 ASP A 500 5 6 HELIX 27 AC9 PHE A 502 CYS A 508 1 7 HELIX 28 AD1 CYS A 508 PHE A 515 1 8 HELIX 29 AD2 PHE A 515 LYS A 520 1 6 HELIX 30 AD3 PHE A 524 TRP A 530 1 7 HELIX 31 AD4 TYR A 532 SER A 537 1 6 HELIX 32 AD5 SER A 561 ALA A 573 1 13 HELIX 33 AD6 CYS A 575 LYS A 579 5 5 HELIX 34 AD7 VAL A 596 ILE A 608 1 13 HELIX 35 AD8 ASN A 610 ALA A 614 5 5 HELIX 36 AD9 SER A 629 ASN A 634 5 6 HELIX 37 AE1 LEU A 638 HIS A 654 1 17 HELIX 38 AE2 THR A 663 LEU A 671 1 9 HELIX 39 AE3 ASN A 676 ILE A 683 5 8 HELIX 40 AE4 ASP A 684 ASN A 697 1 14 HELIX 41 AE5 ASP A 698 LEU A 702 5 5 HELIX 42 AE6 ASN A 736 HIS A 765 1 30 HELIX 43 AE7 PRO A 769 GLN A 774 1 6 HELIX 44 AE8 GLU A 780 GLY A 787 1 8 HELIX 45 AE9 ASP A 792 ASN A 799 1 8 HELIX 46 AF1 ASP A 810 GLU A 821 1 12 HELIX 47 AF2 THR A 824 GLY A 837 1 14 HELIX 48 AF3 GLY A 844 ILE A 849 5 6 HELIX 49 AF4 SER A 887 TYR A 904 1 18 SHEET 1 AA1 2 LEU A 555 VAL A 557 0 SHEET 2 AA1 2 VAL A 584 PHE A 586 1 O ARG A 585 N VAL A 557 SHEET 1 AA2 2 PHE A 616 GLN A 618 0 SHEET 2 AA2 2 PHE A 625 PRO A 627 -1 O GLN A 626 N THR A 617 SHEET 1 AA3 2 SER A 709 ASP A 713 0 SHEET 2 AA3 2 MET A 718 PRO A 722 -1 O GLU A 719 N THR A 712 SHEET 1 AA4 4 GLU A 801 TYR A 802 0 SHEET 2 AA4 4 THR A 859 ALA A 862 1 O ILE A 860 N GLU A 801 SHEET 3 AA4 4 MET A 879 LEU A 882 1 O LEU A 880 N THR A 859 SHEET 4 AA4 4 THR A 872 SER A 874 -1 N THR A 872 O LYS A 881 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000